U.S. BioEnergy, the second largest ethanol producer in the United States, priced its initial public offering of 10 million shares at $14, below its proposed $15 to $17 range, on Thursday night. Despite the reduced offer price, the firm was able to sell 625k shares more than it had originally expected. UBS Investment Bank and Piper Jaffray were the joint book runners on the deal. The stock is expected to begin trading on the NASDAQ under the ticker USBE on Friday.
